Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Toronto

$60,000.00

Tools for advancing the versatility and reliability of RNA editing

FY 2023-24

Summary
The central dogma of molecular biology states that our genetic information, encoded in DNA, is transcribed into RNA, which is subsequently translated into proteins that carry out the functional operations of a cell. One of the most reliable strategies to understand the particular function of a gene is to inactivate or delete its DNA sequence and then subsequently observe the changes that occur in the cells or organism resulting from the loss of the protein. Our ability to perform this task has advanced greatly in the past 15 years due to the discovery of gene editing technologies such as CRISPR/Cas9, which allow researchers to program in a DNA sequence to be edited in a precise manner. An alternative technique is to inactivate the RNA transcripts of a gene, which typically leads to the same end result. While RNA editing can be less efficient due to the fact that there are many more RNA copies of a gene than DNA, its advantages include the possibility of temporal control and reversibility. A primary goal of my research program to design next-generation tools to enable reliable, specific, and cost-effective DNA and RNA editing. The aim of this proposal is to improve the versatility and specificity of CRISPR/Cas13, an RNA editing system. We have recently discovered some small molecules that can inhibit the Cas13 enzyme. In the short term, we will characterize these molecules and test their ability to quickly halt RNA editing in cells. This will be useful for two reasons: it will allow RNA editing to be controlled in a time-dependent or temporal manner, and also allow the degree of RNA editing occurring to be fine-tuned through partial inhibition, expanding the versatility of the system. In addition, we will work to improve the specificity of the system. Many variants of the Cas13 enzyme have been discovered in diverse bacteria. However, the specificity of these systems for cutting or binding to only the programmed sequence has yet to be determined. This is important since off-target cutting of unintended RNAs could confound the interpretation of experimental results. In this proposal we will systematically profile the specificity of these variants to identify the one that demonstrates superior specificity and is the most reliable tool for laboratory researchers. We anticipate that the tools and knowledge stemming from this proposal will make RNA editing more versatile and precise and thereby facilitate gene editing experiments for scientists working in the areas of molecular genetics and molecular biology research. In addition, we hope to patent the chemical tools developed in our first objective and commercialize these, leading to potential economic benefits for Canada. Finally, this proposal will help train and strengthen the competency of Canadian highly-qualified personnel in the use of cutting-edge RNA editing technologies. These skills are highly sought after in the biotechnology sector.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2023-04238
Name nom
Hubbard, Basil
Department département
Pharmacology and Toxicology - Pharmacology and Toxicology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
60000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5402
Research subject group en
Biochemistry
Research subject group fr
Nucleic acids
Research subject en
Biochimie
Research subject fr
Acides nucléiques
Application title
Tools for advancing the versatility and reliability of RNA editing
Keyword
Cas13; Chemical probes; CRISPR; Gene editing; RNA binding specificity; RNA cleavage specificity; RNA editing; Small-molecule inhibitors; Temporal control of RNA editing in mammalian cells; Titration of RNA editing effect
Application summary
The central dogma of molecular biology states that our genetic information, encoded in DNA, is transcribed into RNA, which is subsequently translated into proteins that carry out the functional operations of a cell. One of the most reliable strategies to understand the particular function of a gene is to inactivate or delete its DNA sequence and then subsequently observe the changes that occur in the cells or organism resulting from the loss of the protein. Our ability to perform this task has advanced greatly in the past 15 years due to the discovery of gene editing technologies such as CRISPR/Cas9, which allow researchers to program in a DNA sequence to be edited in a precise manner. An alternative technique is to inactivate the RNA transcripts of a gene, which typically leads to the same end result. While RNA editing can be less efficient due to the fact that there are many more RNA copies of a gene than DNA, its advantages include the possibility of temporal control and reversibility. A primary goal of my research program to design next-generation tools to enable reliable, specific, and cost-effective DNA and RNA editing. The aim of this proposal is to improve the versatility and specificity of CRISPR/Cas13, an RNA editing system. We have recently discovered some small molecules that can inhibit the Cas13 enzyme. In the short term, we will characterize these molecules and test their ability to quickly halt RNA editing in cells. This will be useful for two reasons: it will allow RNA editing to be controlled in a time-dependent or temporal manner, and also allow the degree of RNA editing occurring to be fine-tuned through partial inhibition, expanding the versatility of the system. In addition, we will work to improve the specificity of the system. Many variants of the Cas13 enzyme have been discovered in diverse bacteria. However, the specificity of these systems for cutting or binding to only the programmed sequence has yet to be determined. This is important since off-target cutting of unintended RNAs could confound the interpretation of experimental results. In this proposal we will systematically profile the specificity of these variants to identify the one that demonstrates superior specificity and is the most reliable tool for laboratory researchers. We anticipate that the tools and knowledge stemming from this proposal will make RNA editing more versatile and precise and thereby facilitate gene editing experiments for scientists working in the areas of molecular genetics and molecular biology research. In addition, we hope to patent the chemical tools developed in our first objective and commercialize these, leading to potential economic benefits for Canada. Finally, this proposal will help train and strengthen the competency of Canadian highly-qualified personnel in the use of cutting-edge RNA editing technologies. These skills are highly sought after in the biotechnology sector.